RxDoctor Payments Data

Abisoye Fakayode

Internal Medicine · Hammonton, NJNPI 1225415227

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $714 and has fallen 97.0% since, to $22 in 2023.

$1,459in general payments, 2019–2025

Across 83 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$169
  • Esperion Therapeutics, Inc.$147
  • Novo Nordisk$141
  • AbbVie$96
  • AstraZeneca$94
  • Kowa Pharmaceuticals America, Inc.$93
  • plus $718 from 18 others

What the payments were for

  • Food & beverage$1,459100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,459 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Other internal medicine in Hammonton

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →